---
title: "002424.SZ (002424.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002424.SZ/news.md"
symbol: "002424.SZ"
name: "002424.SZ"
parent: "https://longbridge.com/en/quote/002424.SZ.md"
datetime: "2026-03-14T16:22:36.923Z"
locales:
  - [en](https://longbridge.com/en/quote/002424.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002424.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002424.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/002424.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/002424.SZ/news.md)


# 002424.SZ (002424.SZ) — Related News

### [Guizhou Bailin: Compound One-Branch Yellow Flower Spray Approved for Expanded Use in Children](https://longbridge.com/en/news/277582464.md)
*2026-03-03T07:59:34.000Z*
> Guizhou Bailin announced that its compound goldenrod spray has been approved by the National Medical Products Administra

### [GZBL: Abnormal fluctuations in stock trading; there are no undisclosed significant matters that should be disclosed](https://longbridge.com/en/news/277444562.md)
*2026-03-02T10:15:13.000Z*
> ST GZBL announced that the company's stock price has deviated by more than 12% over three consecutive trading days, whic

### [GZBL: The application for the compound one-branch golden flower spray meets the drug registration requirements](https://longbridge.com/en/news/277428316.md)
*2026-03-02T08:22:22.000Z*
> ST GZBL announced that it recently received the "Drug Supplement Application Approval Notice" issued by the National Med

### [Multiple factors lead to a projected net loss in 2025 for ST GZBL: overall operations remain stable](https://longbridge.com/en/news/274314096.md)
*2026-01-30T13:07:23.000Z*
> On the evening of January 30th, ST GZBL (002424) disclosed its performance forecast for the year 2025, expecting a net p

### [Intraday News - Longhua (2424) plummets 3% to 41.2 yuan, with a trading volume of 342 shares](https://longbridge.com/en/news/274080117.md)
*2026-01-29T02:51:05.000Z*
> Longhua (2424-TW) stock price plummeted 3% at 10:51 on the 29th, reporting at NT$ 41.2, with a trading volume of 342 lot

### [Guizhou Bailing: Obtained patent acceptance for "a traditional Chinese medicine preparation for the treatment of diabetes or its complications."](https://longbridge.com/en/news/272536715.md)
*2026-01-14T10:35:36.000Z*
> Guizhou Bailing recently announced that the company has received a patent application acceptance notice from the Nationa

### [ST GZBL: The cumulative deviation value of the stock price decline over three consecutive days exceeds 12%, indicating an abnormal fluctuation situation](https://longbridge.com/en/news/270780137.md)
*2025-12-25T08:46:01.000Z*
> ST GZBL announced that the company's stock price has deviated by more than 12% over three consecutive trading days, indi

### [GZBL was fined 10 million yuan for false reporting in its annual report, and the chairman was banned from the market for 10 years](https://longbridge.com/en/news/270313362.md)
*2025-12-19T13:19:14.000Z*
> GZBL was fined 10 million yuan by the China Securities Regulatory Commission for false reporting in its annual report, a

### [The Guizhou Securities Regulatory Bureau has strictly investigated and dealt with the financial fraud case of GZBL](https://longbridge.com/en/news/270305509.md)
*2025-12-19T12:33:14.000Z*
> Recently, the Guizhou Regulatory Bureau of the China Securities Regulatory Commission (Guizhou CSRC) issued an administr

### [GZBL: Due to false records in the annual reports from 2019 to 2021 and the 2023 annual report, other risk warnings have been implemented, and the stock abbreviation will be changed to "ST GZBL"](https://longbridge.com/en/news/270305404.md)
*2025-12-19T12:32:13.000Z*
> GZBL was warned for false records in the annual reports from 2019 to 2021 and in 2023, and its stock abbreviation has be